Article
Prognostic significance of HER-2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinoma
1 Jun 1997
Abstract excerpt
BACKGROUND: HER-2/neu gene amplification, established as a prognostic factor in breast carcinoma and other cancers, has not been correlated with outcome in prostate carcinomas (PCs). METHODS: HER-2/neu gene amplification was determined by automated fluorescence in situ hybridization (FISH) using a unique sequence cosmid probe on 113 formalin fixed, paraffin embedded 4-microns tissue sections and the results...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
